Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

ASH2025

Mariasanta Napolitano on Pregnancy and Delivery Outcomes in Women with Hemophilia
Jan 11, 2026, 10:36 | Science
Mariasanta Napolitano on Pregnancy and Delivery Outcomes in Women with Hemophilia
Mariasanta Napolitano, Associate Professor of Hematology at the University of Palermo, shared on LinkedIn: ''I’m…
Last day at ASH25 from Riten Kumar
Jan 10, 2026, 14:40 | Insight
Last day at ASH25 from Riten Kumar
Riten Kumar, Director of Thrombosis and Anticoagulation at Dana-Farber/Boston Children’s Cancer and Blood Disorders Center,…
Glaivy Batsuli Reflects on ASH25
Jan 7, 2026, 05:15 | Voices
Glaivy Batsuli Reflects on ASH25
Glaivy Batsuli, Associate Professor of Pediatrics at Stanford University School of Medicine, shared on LinkedIn:…
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Jan 4, 2026, 21:39 | Insight
Sriveda Boyalakuntla Takes The ASH25 Abstract Achievement Award
Sriveda Boyalakuntla, Volunteer at Mass General Hospital, shared on LinkedIn: ''Grateful for the opportunity to…
Anusha T's First ASH Presentation: Combined Factor V and VIII Deficiency
Dec 29, 2025, 23:04 | Voices
Anusha T's First ASH Presentation: Combined Factor V and VIII Deficiency
Anusha T, Consultant Hematopathologist at HCG Cancer Center Bengaluru, shared a post on LinkedIn: "Humbled and…
Aashka Shah Takes ASH25 Abstract Achievement Award!
Dec 26, 2025, 16:45 | Insight
Aashka Shah Takes ASH25 Abstract Achievement Award!
Aashka Shah, Teaching Assistant, Elementary Microbiology Lab (MICRB 107) at Penn State University, shared on…
ASH25: Over 8,200 Hematology Abstracts Now Available
Dec 24, 2025, 01:17 | Organizations
ASH25: Over 8,200 Hematology Abstracts Now Available
Blood Journals Portfolio posted on LinkedIn: ''Our 67th Annual Meeting may be over, but the…
Leigh Anne Siino on The Spherix Global's Translation of ASH25 Insights Into Actionable Intelligence
Dec 23, 2025, 12:56 | Insight
Leigh Anne Siino on The Spherix Global's Translation of ASH25 Insights Into Actionable Intelligence
Leigh Anne Siino, Chief Revenue Officer at Spherix Global Insights, shared on LinkedIn: ''The Spherix…
Danny Hsu: Another Excellent Post from Wolfgang Miesbach - Comparing Low and Standard Dose Rituximab in iTTP
Dec 22, 2025, 12:38 | Science
Danny Hsu: Another Excellent Post from Wolfgang Miesbach - Comparing Low and Standard Dose Rituximab in iTTP
Danny Hsu, President of THANZ, reposted from Wolfgang Miesbach on LinkedIn: "As DJ Khaled would…
John Strouse: Grateful for ASH’s Support and for the Privilege of Working with Charity Oyedeji
Dec 20, 2025, 23:17 | Organizations
John Strouse: Grateful for ASH’s Support and for the Privilege of Working with Charity Oyedeji
John Strouse, Associate Professor of Medicine at Duke University Medical Center, shared on LinkedIn: "I am…
Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
Dec 20, 2025, 16:13 | Insight
Akshat Jain Explains VWF/FVIII Prophylaxis in Children Under 6
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:…
Dato Capt. Mahesan Subramaniam: Groundbreaking Gene Therapy Wipes Out “Incurable” Leukemia in 64% of Patients
Dec 19, 2025, 23:11 | Science
Dato Capt. Mahesan Subramaniam: Groundbreaking Gene Therapy Wipes Out “Incurable” Leukemia in 64% of Patients
Dato Capt. Mahesan Subramaniam, Co-Founder of United Health Tourism, posted on LinkedIn: "Groundbreaking gene therapy wipes out…
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Dec 19, 2025, 10:51 | Insight
Sarah Elkourashy Presents Insights on Caplacizumab for TTP at ASH25
Sarah Elkourashy, Consultant in Clinical Hematology and BMT at Hamad Medical Corporation, Assistant professor of…
Wolfgang Miesbach: Predicting Breakthrough Bleeding in Emicizumab-Treated Acquired Haemophilia A
Dec 18, 2025, 23:23 | Science
Wolfgang Miesbach: Predicting Breakthrough Bleeding in Emicizumab-Treated Acquired Haemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "Predicting Breakthrough Bleeding in…
The "Normal" FVIII Level Trap in Females with Haemophilia
Dec 18, 2025, 23:14 | Science
The "Normal" FVIII Level Trap in Females with Haemophilia
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, posted on LinkedIn: ''The "Normal" FVIII…
Marie Cambot on Innovhem's Quantification of The HbF/HbS Ratio for SCD
Dec 18, 2025, 16:50 | Voices
Marie Cambot on Innovhem's Quantification of The HbF/HbS Ratio for SCD
Marie Cambot, Co founder and CEO at INNOVHEM, reposted from INNOVHEM on LinkedIn: ''Many thanks to…
Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Dec 18, 2025, 16:09 | Insight
Carlos Doti: I’m Reminded Why ASH is Such a Powerful Close to The Year
Carlos Doti, VP US Medical Affairs Oncology at AstraZeneca, shared on LinkedIn: ''As I reflect…
Wolfgang Miesbach on Insights from Guy Young's ASH2025 Session on Next-Generation Gene Therapy
Dec 18, 2025, 15:12 | Insight
Wolfgang Miesbach on Insights from Guy Young's ASH2025 Session on Next-Generation Gene Therapy
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''The Immunogenicity Challenge…
Wolfgang Miesbach: Rituximab Dose Optimization in iTTP - Why Standard Dose is Preferred?
Dec 17, 2025, 23:55 | Drugs
Wolfgang Miesbach: Rituximab Dose Optimization in iTTP - Why Standard Dose is Preferred?
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "ASH25 Data: Rituximab Dose…
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Dec 17, 2025, 06:28 | Insight
Wolfgang Miesbach on Linus Völker's Presentation of Caplacizumab as Frontline Therapy for iTTP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''Caplacizumab as Frontline…
Andrius Žučenka: Congratulations to All the Investigators Involved in the PARADIGM trial
Dec 15, 2025, 13:22 | Insight
Andrius Žučenka: Congratulations to All the Investigators Involved in the PARADIGM trial
Andrius Žučenka, Assistant professor at Vilniaus universitetas / Vilnius University, shared a post on LinkedIn: "First…
Wolfgang Miesbach Shares Insights from Davide Matino's Presentation on Marstacimab at ASH25
Dec 15, 2025, 11:28 | Insight
Wolfgang Miesbach Shares Insights from Davide Matino's Presentation on Marstacimab at ASH25
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''ASH25: Introducing fixed-dose…
ADOPT Phase 4 Interim Analysis: Avatrombopag in Chronic ITP
Dec 15, 2025, 09:36 | Insight
ADOPT Phase 4 Interim Analysis: Avatrombopag in Chronic ITP
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, posted on LinkedIn: ''ADOPT Phase 4…
NNHF Unveiled at ASH2025: Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
Dec 14, 2025, 16:04 | Organizations
NNHF Unveiled at ASH2025: Expanding Beyond Haemophilia Care to Include SCD and Thalassemia
Amos Gitonga M, Associate Programme Manager-Southern Africa at Novo Nordisk Haemophilia and Haemoglobinopathies Foundation, shared a…
Colleen Silk on Novo Nordisk Performance at ASH25
Dec 14, 2025, 15:07 | Voices
Colleen Silk on Novo Nordisk Performance at ASH25
Colleen Silk, Corporate Vice President, Rare Disease at Novo Nordisk, shared on LinkedIn: ''I’m so…
Dino Mehic with Colleagues: BDUC - What is It and What Do We Know?
Dec 14, 2025, 13:14 | Insight
Dino Mehic with Colleagues: BDUC - What is It and What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn: "Bleeding Disorder…
All the Amazing Senior Editors from Blood Journals Portfolio Together at ASH25
Dec 14, 2025, 13:13 | Insight
All the Amazing Senior Editors from Blood Journals Portfolio Together at ASH25
Blood Journals Portfolio posted on LinkedIn: "Today we got all of the amazing Senior Editors together…
Mentored by Riten Kumar, Sriveda Boyalakuntla Presents Key Research on Infection-Associated Thrombosis at ASH25
Dec 14, 2025, 12:56 | Science
Mentored by Riten Kumar, Sriveda Boyalakuntla Presents Key Research on Infection-Associated Thrombosis at ASH25
Kishore Boyalakuntla, GM and CPO at Re:Build Cadonix, reposted Riten Kumar's post on LinkedIn: "Congrats Sriveda Boyalakuntla on…
An Important Step Forward in ITP: Shreeram Aradhye Shares Ianalumab Phase III Results!
Dec 13, 2025, 15:20 | Drugs
An Important Step Forward in ITP: Shreeram Aradhye Shares Ianalumab Phase III Results!
Shreeram Aradhye, President, Development and Chief Medical Officer at Novartis, shared on LinkedIn: ''Today, at…
Wolfgang Miesbach: New FVIII‑QQ Gene Therapy Aims for "Less is More" – Durable Expression with Enhanced Potency
Dec 13, 2025, 07:44 | Science
Wolfgang Miesbach: New FVIII‑QQ Gene Therapy Aims for "Less is More" – Durable Expression with Enhanced Potency
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "Less is more: How enhanced‑function…
Don't Miss: IACH Post ASH 2025 Roundtable Debate
Dec 12, 2025, 23:51 | Organizations
Don't Miss: IACH Post ASH 2025 Roundtable Debate
International Academy for Clinical Hematology (IACH) shared a post on LinkedIn: "Don't miss the upcoming IACH…
8 Posts Not to Miss From the ASH 2025 – Marc Carrier
Dec 12, 2025, 14:47 | Insight
8 Posts Not to Miss From the ASH 2025 – Marc Carrier
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
Steve Tuplin on A New Era in Haemophilia A Care: Reflections from ASH25
Dec 12, 2025, 06:48 | Voices
Steve Tuplin on A New Era in Haemophilia A Care: Reflections from ASH25
Steve Tuplin, VP, Global Disease Area Head – Hematology and ai Oncology at Roche, shared…
Preoperative Platelet Transfusion: Outcomes vs Guideline Thresholds
Dec 11, 2025, 23:40 | Science
Preoperative Platelet Transfusion: Outcomes vs Guideline Thresholds
José Antonio García Erce, Director of the Donation Center, Navarre Health Service (Osasunbidea), shared on…
Denise Braendgaard: NNHF Marks Defining Moment at ASH2025
Dec 11, 2025, 23:30 | Insight
Denise Braendgaard: NNHF Marks Defining Moment at ASH2025
Denise Braendgaard, General Manager of  Novo Nordisk Haemophilia & Haemoglobinopathies Foundation, posted on  LinkedIn: ''A…
Kristof Vercruysse on ''First in Human'' Presented at ASH25
Dec 11, 2025, 15:05 | Insight
Kristof Vercruysse on ''First in Human'' Presented at ASH25
Kristof Vercruysse, CEO and Co-Founder at TargED Biopharmaceuticals, reposted from TargED Biopharmaceuticals on LinkedIn: ''Back in…
Zoey Becker: CSL Proves Efficacy of Hemophilia B Gene Therapy Hemgenix Holds up After 5 Years
Dec 11, 2025, 12:12 | Science
Zoey Becker: CSL Proves Efficacy of Hemophilia B Gene Therapy Hemgenix Holds up After 5 Years
Brian James, Chief Operating Officer at Rondaxe Pharma LLC, shared an article on LinkedIn: "Are the…
Dino Mehic on BDUC: What Do We Know?
Dec 11, 2025, 11:55 | Science
Dino Mehic on BDUC: What Do We Know?
Dino Mehic, Physician Scientist at the Medical University of Vienna, shared on LinkedIn: ''Bleeding Disorder…
Post‑ASH25 Reflection from Hollie Knight: The Magic Isn’t Just in the Data, It’s in How We Move It
Dec 11, 2025, 11:39 | Voices
Post‑ASH25 Reflection from Hollie Knight: The Magic Isn’t Just in the Data, It’s in How We Move It
Hollie Knight, Executive Director at Vaniam Group, shared on LinkedIn: ''Post‑ASH25 reflection: the magic isn’t…
Susan Galbraith on AstraZeneca's Grand Presence at ASH25
Dec 10, 2025, 22:36 | Insight
Susan Galbraith on AstraZeneca's Grand Presence at ASH25
Susan Galbraith, Executive Vice President Oncology Haematology R&D at AstraZeneca, shared on LinkedIn: ''It’s been…
12 Posts Not to Miss From the ASH 2025 – Wolfgang Miesbach
Dec 10, 2025, 22:02 | Insight
12 Posts Not to Miss From the ASH 2025 – Wolfgang Miesbach
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
In the Fight for Hematology: Adetokunbo O's Reflections from ASH25
Dec 10, 2025, 17:22 | Voices
In the Fight for Hematology: Adetokunbo O's Reflections from ASH25
Adetokunbo O, Medical Director - Oncology at AbbVie, shared on LinkedIn: ''I’m leaving the 67th…
Driving Innovation in Rare Blood Disorders: Jeff Schaffnit's ASH 2025 Perspective
Dec 10, 2025, 17:11 | Insight
Driving Innovation in Rare Blood Disorders: Jeff Schaffnit's ASH 2025 Perspective
Jeff Schaffnit, General Manager and Head of Rare Blood Disorders at Sanofi, shared on LinkedIn:…
Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
Dec 10, 2025, 16:14 | Voices
Yashpal Singh Rawat: Fortis Memorial Research Institute Made Its Positive Mark at ASH
Yashpal Singh Rawat, Vice President and Facility Director at Fortis Healthcare, shared on LinkedIn: ''Fortis…
Aakanksha A: A Highlight of the Week Was Presenting Our ASH Poster
Dec 10, 2025, 13:37 | Insight
Aakanksha A: A Highlight of the Week Was Presenting Our ASH Poster
Aakanksha A, Senior Manager, Learning Scientist at American Society of Hematology, shared on LinkedIn: ''Just…
ASH25: Wolfgang Miesbach on Why No Single Haemophilia Therapy Is the “Winner”
Dec 10, 2025, 05:09 | Science
ASH25: Wolfgang Miesbach on Why No Single Haemophilia Therapy Is the “Winner”
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: The "Paradox of…
ASH Welcomes Dr. Robert Negrin: The Gavel has Officially Passed
Dec 10, 2025, 04:58 | Insight
ASH Welcomes Dr. Robert Negrin: The Gavel has Officially Passed
ASH shared on X: "The gavel has officially passed at ASH25. Thank you, Dr. Avalos, for…
Akshat Jain: Key Takeaways from ASH2025: Transformative Therapeutics, Global Insight, and Compassionate Innovation
Dec 10, 2025, 04:57 | Voices
Akshat Jain: Key Takeaways from ASH2025: Transformative Therapeutics, Global Insight, and Compassionate Innovation
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn: "What…
ASH25 Day 4: Don’t Miss The Highlights
Dec 9, 2025, 23:21 | Insight
ASH25 Day 4: Don’t Miss The Highlights
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
Aimn Abdujawad and Collaegues: A Quality Improvement Project to Optimize IVC Filter Use and Retrieval and Other More Projects at the ASH
Dec 9, 2025, 13:34 | Science
Aimn Abdujawad and Collaegues: A Quality Improvement Project to Optimize IVC Filter Use and Retrieval and Other More Projects at the ASH
Aimn Abdujawad, Quality Improvement Specialist at Ministry of National Guard Health Affairs (MNGHA), posted on…
Riten Kumar: Highlights From Day 2 of ASH25
Dec 9, 2025, 13:27 | Insight
Riten Kumar: Highlights From Day 2 of ASH25
Riten Kumar, Associate Professor of Pediatrics at Harvard Medical School and Director of Thrombosis and…
Dr. Abdul Muqtadir Abbasi: The Effect of Recombinant Factor VIIa Treatment in Non-Traumatic Intracranial Hemorrhage
Dec 9, 2025, 13:25 | Insight
Dr. Abdul Muqtadir Abbasi: The Effect of Recombinant Factor VIIa Treatment in Non-Traumatic Intracranial Hemorrhage
Dr. Abdul Muqtadir Abbasi, Assistant Consultant at King Faisal Specialist Hospital and Research Center, shared a…
Maria Elisa Mancuso on NXT007 Prophylaxis in People With Haemophilia A
Dec 9, 2025, 09:06 | Science
Maria Elisa Mancuso on NXT007 Prophylaxis in People With Haemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn: "Maria…
Cedric Hermans Presenting FRONTIER2 Data on Mim8 in Adolescents and Adults with Haemophilia A
Dec 9, 2025, 09:00 | Science
Cedric Hermans Presenting FRONTIER2 Data on Mim8 in Adolescents and Adults with Haemophilia A
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "What matters most – patient…
Muhammad Awidi: IV Iron During Acute Infection Shows Improved Outcomes
Dec 9, 2025, 08:42 | Science
Muhammad Awidi: IV Iron During Acute Infection Shows Improved Outcomes
Muhammad Awidi, Hematology and Oncology Fellow at Roswell Park Cancer Center, reposted from Andreas Tiede…
Amy H. Huang: Our Work on Bone Health in Myeloma Has Been Recognized with ASH Abstract Achievement Award
Dec 9, 2025, 08:02 | Voices
Amy H. Huang: Our Work on Bone Health in Myeloma Has Been Recognized with ASH Abstract Achievement Award
Amy H. Huang, Internal Medicine Resident Physician at University of Connecticut, posted on X: "Excited to share…
Grigoris Gerotziafas: 3 ASH 2025 Poster Awards for Our Team!
Dec 9, 2025, 04:47 | Insight
Grigoris Gerotziafas: 3 ASH 2025 Poster Awards for Our Team!
Grigoris Gerotziafas, Director of the Cancer, Vessels, Biology, and Therapeutics (CaVITE) Research Department, Head of…
ASH25 Day 3: Don’t Miss The Highlights
Dec 8, 2025, 22:24 | Insight
ASH25 Day 3: Don’t Miss The Highlights
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
Jorge Di Paola and Diane Krause Take Their Awards at ASH25
Dec 8, 2025, 11:23 | Voices
Jorge Di Paola and Diane Krause Take Their Awards at ASH25
Blood Journals Portfolio shared on LinkedIn: ''Congratulations to two special award recipients at ASH25 today,…
Andreas Tiede: This Will Change Hematology Forever
Dec 8, 2025, 11:08 | Insight
Andreas Tiede: This Will Change Hematology Forever
Andreas Tiede, Professor, Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School,…
Asfand Yar Cheema Honored with Abstract Achievement Awards at ASH25
Dec 8, 2025, 09:39 | Voices
Asfand Yar Cheema Honored with Abstract Achievement Awards at ASH25
Asfand Yar Cheema, Resident Physician at Cleveland Clinic, Founder of Ask a Doctor, shared on…
Dr. Mysa Saad Had Her First Oral Presentation at ASH25
Dec 8, 2025, 08:35 | Drugs,Organizations
Dr. Mysa Saad Had Her First Oral Presentation at ASH25
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared on X: "Congrats to Dr. Mysa Saad on…
Moffitt Cancer Center Hematology Oncology Fellows Conquering ASH25 in Style
Dec 8, 2025, 08:29 | Insight
Moffitt Cancer Center Hematology Oncology Fellows Conquering ASH25 in Style
Moffitt Hematology/Oncology Fellowship shared a post on X: "Moffitt Cancer Center hematology oncology fellows conquering ASH25…
ASH25 Highlight - Extended Anticoagulation in VTE: Apixaban vs Rivaroxaban
Dec 8, 2025, 08:27 | Science
ASH25 Highlight - Extended Anticoagulation in VTE: Apixaban vs Rivaroxaban
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared on LinkedIn: ''ASH25 Highlight - Extended…
New ASH25 Insights on Bleeding Risk in Cancer-Associated VTE
Dec 8, 2025, 06:23 | Science
New ASH25 Insights on Bleeding Risk in Cancer-Associated VTE
Marc Carrier, Professor at Ottawa Hospital Research Institute, shared on LinkedIn: ''New Insights on Bleeding…
Wolfgang Miesbach on Landmark 5-Year Haemophilia B Gene Therapy Results
Dec 8, 2025, 06:22 | Insight
Wolfgang Miesbach on Landmark 5-Year Haemophilia B Gene Therapy Results
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: ''Visualizing 5-year outcomes…
ASH2025: Key Cancer Associated VTE Insights
Dec 8, 2025, 06:17 | Organizations
ASH2025: Key Cancer Associated VTE Insights
Jean Connors, Chief of Cancer Hematology at Dana-Farber Cancer Institute, posted on LinkedIn: ''ASH2025 clots…
ASH 2025 Spotlight: Transformative Sickle Cell Disease Clinical Developments
Dec 8, 2025, 06:10 | Science
ASH 2025 Spotlight: Transformative Sickle Cell Disease Clinical Developments
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn:…
ASH25 Day 2: Don't Miss The Highlights
Dec 7, 2025, 18:43 | Insight
ASH25 Day 2: Don't Miss The Highlights
The American Society of Hematology Congress 2025 (ASH25) is officially underway in Orlando, Florida, from…
Jean Connors: Great Start to ASH2025 with Thrombosis Session Lead
Dec 7, 2025, 06:09 | Voices
Jean Connors: Great Start to ASH2025 with Thrombosis Session Lead
Jean Connors, Chief of Cancer Hematology at Dana-Farber Cancer Institute, posted on LinkedIn: ''Great start…
Wolfgang Miesbach: iTTP Remission ≠ Cure. The Vascular Injury Persists
Dec 7, 2025, 05:50 | Science
Wolfgang Miesbach: iTTP Remission ≠ Cure. The Vascular Injury Persists
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared on LinkedIn: "iTTP remission ≠ cure.…
Akshat Jain: It was Wonderful Hosting and Meeting Industry Leaders on Their Visit Down to Southern California
Dec 6, 2025, 06:34 | Voices
Akshat Jain: It was Wonderful Hosting and Meeting Industry Leaders on Their Visit Down to Southern California
Akshat Jain, Hematology Pediatric Workforce Task Force at American Society of Hematology, shared on LinkedIn: "It…
Mohamad Mohty: What’s in My ASH25 Starter Pack?
Dec 6, 2025, 06:29 | Voices
Mohamad Mohty: What’s in My ASH25 Starter Pack?
Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne…
All: 73 Posts: 1 - 100
NewsFeed